![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: FNIP1 |
Gene summary for FNIP1 |
![]() |
Gene information | Species | Human | Gene symbol | FNIP1 | Gene ID | 96459 |
Gene name | folliculin interacting protein 1 | |
Gene Alias | FNIP1 | |
Cytomap | 5q31.1 | |
Gene Type | protein-coding | GO ID | GO:0000122 | UniProtAcc | Q8TF40 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
96459 | FNIP1 | LZE4T | Human | Esophagus | ESCC | 2.64e-10 | 3.61e-01 | 0.0811 |
96459 | FNIP1 | LZE5T | Human | Esophagus | ESCC | 9.34e-04 | 2.66e-01 | 0.0514 |
96459 | FNIP1 | LZE7T | Human | Esophagus | ESCC | 4.98e-06 | 2.87e-01 | 0.0667 |
96459 | FNIP1 | LZE8T | Human | Esophagus | ESCC | 2.67e-13 | 2.61e-01 | 0.067 |
96459 | FNIP1 | LZE20T | Human | Esophagus | ESCC | 1.11e-05 | 1.54e-01 | 0.0662 |
96459 | FNIP1 | LZE21D1 | Human | Esophagus | HGIN | 4.99e-03 | 1.67e-01 | 0.0632 |
96459 | FNIP1 | LZE22D1 | Human | Esophagus | HGIN | 3.99e-02 | 1.04e-01 | 0.0595 |
96459 | FNIP1 | LZE22T | Human | Esophagus | ESCC | 4.69e-09 | 6.20e-01 | 0.068 |
96459 | FNIP1 | LZE24T | Human | Esophagus | ESCC | 1.66e-19 | 3.36e-01 | 0.0596 |
96459 | FNIP1 | LZE21T | Human | Esophagus | ESCC | 3.85e-06 | 3.32e-01 | 0.0655 |
96459 | FNIP1 | LZE6T | Human | Esophagus | ESCC | 1.29e-04 | 1.54e-01 | 0.0845 |
96459 | FNIP1 | P1T-E | Human | Esophagus | ESCC | 7.84e-12 | 3.35e-01 | 0.0875 |
96459 | FNIP1 | P2T-E | Human | Esophagus | ESCC | 3.93e-35 | 4.72e-01 | 0.1177 |
96459 | FNIP1 | P4T-E | Human | Esophagus | ESCC | 8.64e-19 | 4.01e-01 | 0.1323 |
96459 | FNIP1 | P5T-E | Human | Esophagus | ESCC | 6.64e-18 | 2.29e-01 | 0.1327 |
96459 | FNIP1 | P8T-E | Human | Esophagus | ESCC | 9.24e-23 | 3.05e-01 | 0.0889 |
96459 | FNIP1 | P9T-E | Human | Esophagus | ESCC | 2.13e-18 | 3.39e-01 | 0.1131 |
96459 | FNIP1 | P10T-E | Human | Esophagus | ESCC | 1.67e-28 | 3.93e-01 | 0.116 |
96459 | FNIP1 | P11T-E | Human | Esophagus | ESCC | 3.92e-16 | 4.77e-01 | 0.1426 |
96459 | FNIP1 | P12T-E | Human | Esophagus | ESCC | 2.35e-28 | 4.58e-01 | 0.1122 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:004328118 | Prostate | BPH | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 71/3107 | 209/18723 | 5.88e-10 | 2.89e-08 | 71 |
GO:005254818 | Prostate | BPH | regulation of endopeptidase activity | 122/3107 | 432/18723 | 6.10e-10 | 2.91e-08 | 122 |
GO:003166817 | Prostate | BPH | cellular response to extracellular stimulus | 79/3107 | 246/18723 | 1.32e-09 | 5.69e-08 | 79 |
GO:200011618 | Prostate | BPH | regulation of cysteine-type endopeptidase activity | 76/3107 | 235/18723 | 1.90e-09 | 7.79e-08 | 76 |
GO:004586118 | Prostate | BPH | negative regulation of proteolysis | 98/3107 | 351/18723 | 5.43e-08 | 1.49e-06 | 98 |
GO:003166910 | Prostate | BPH | cellular response to nutrient levels | 67/3107 | 215/18723 | 8.51e-08 | 2.12e-06 | 67 |
GO:000926710 | Prostate | BPH | cellular response to starvation | 52/3107 | 156/18723 | 2.24e-07 | 4.89e-06 | 52 |
GO:003166718 | Prostate | BPH | response to nutrient levels | 121/3107 | 474/18723 | 3.68e-07 | 7.70e-06 | 121 |
GO:004259410 | Prostate | BPH | response to starvation | 59/3107 | 197/18723 | 2.10e-06 | 3.45e-05 | 59 |
GO:200011716 | Prostate | BPH | negative regulation of cysteine-type endopeptidase activity | 31/3107 | 86/18723 | 1.01e-05 | 1.40e-04 | 31 |
GO:005134616 | Prostate | BPH | negative regulation of hydrolase activity | 94/3107 | 379/18723 | 2.46e-05 | 2.94e-04 | 94 |
GO:004315415 | Prostate | BPH | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 28/3107 | 78/18723 | 2.91e-05 | 3.34e-04 | 28 |
GO:19015322 | Prostate | BPH | regulation of hematopoietic progenitor cell differentiation | 15/3107 | 32/18723 | 6.38e-05 | 6.36e-04 | 15 |
GO:001095115 | Prostate | BPH | negative regulation of endopeptidase activity | 66/3107 | 252/18723 | 6.87e-05 | 6.78e-04 | 66 |
GO:00181059 | Prostate | BPH | peptidyl-serine phosphorylation | 79/3107 | 315/18723 | 7.09e-05 | 6.96e-04 | 79 |
GO:001046616 | Prostate | BPH | negative regulation of peptidase activity | 68/3107 | 262/18723 | 7.28e-05 | 7.13e-04 | 68 |
GO:00182097 | Prostate | BPH | peptidyl-serine modification | 82/3107 | 338/18723 | 1.73e-04 | 1.48e-03 | 82 |
GO:00022444 | Prostate | BPH | hematopoietic progenitor cell differentiation | 34/3107 | 114/18723 | 3.08e-04 | 2.37e-03 | 34 |
GO:19031315 | Prostate | BPH | mononuclear cell differentiation | 98/3107 | 426/18723 | 3.43e-04 | 2.55e-03 | 98 |
GO:00300982 | Prostate | BPH | lymphocyte differentiation | 83/3107 | 374/18723 | 2.76e-03 | 1.46e-02 | 83 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa041505 | Esophagus | ESCC | mTOR signaling pathway | 98/4205 | 156/8465 | 5.81e-04 | 1.95e-03 | 9.97e-04 | 98 |
hsa0415013 | Esophagus | ESCC | mTOR signaling pathway | 98/4205 | 156/8465 | 5.81e-04 | 1.95e-03 | 9.97e-04 | 98 |
hsa041502 | Liver | HCC | mTOR signaling pathway | 95/4020 | 156/8465 | 4.70e-04 | 1.99e-03 | 1.11e-03 | 95 |
hsa0415011 | Liver | HCC | mTOR signaling pathway | 95/4020 | 156/8465 | 4.70e-04 | 1.99e-03 | 1.11e-03 | 95 |
hsa041504 | Oral cavity | OSCC | mTOR signaling pathway | 90/3704 | 156/8465 | 2.87e-04 | 9.15e-04 | 4.66e-04 | 90 |
hsa0415012 | Oral cavity | OSCC | mTOR signaling pathway | 90/3704 | 156/8465 | 2.87e-04 | 9.15e-04 | 4.66e-04 | 90 |
hsa0415021 | Oral cavity | EOLP | mTOR signaling pathway | 34/1218 | 156/8465 | 7.59e-03 | 2.17e-02 | 1.28e-02 | 34 |
hsa041503 | Oral cavity | EOLP | mTOR signaling pathway | 34/1218 | 156/8465 | 7.59e-03 | 2.17e-02 | 1.28e-02 | 34 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
FNIP1 | SNV | Missense_Mutation | c.3239C>G | p.Ser1080Cys | p.S1080C | Q8TF40 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-A8-A06Q-01 | Breast | breast invasive carcinoma | Female | <65 | III/IV | Unknown | Unknown | SD | |
FNIP1 | SNV | Missense_Mutation | rs148075882 | c.3071N>A | p.Arg1024His | p.R1024H | Q8TF40 | protein_coding | deleterious(0) | possibly_damaging(0.891) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FNIP1 | SNV | Missense_Mutation | novel | c.1175N>A | p.Arg392Gln | p.R392Q | Q8TF40 | protein_coding | deleterious(0) | possibly_damaging(0.767) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
FNIP1 | SNV | Missense_Mutation | c.1334N>G | p.Asn445Ser | p.N445S | Q8TF40 | protein_coding | deleterious(0.01) | benign(0.037) | TCGA-AR-A0U0-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
FNIP1 | SNV | Missense_Mutation | c.668N>T | p.Gly223Val | p.G223V | Q8TF40 | protein_coding | deleterious(0.03) | probably_damaging(0.982) | TCGA-AR-A1AQ-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | SD | |
FNIP1 | insertion | Frame_Shift_Ins | novel | c.3310_3311insGCACAAGGGA | p.Val1104GlyfsTer8 | p.V1104Gfs*8 | Q8TF40 | protein_coding | TCGA-AR-A0U0-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
FNIP1 | SNV | Missense_Mutation | novel | c.1598N>G | p.Gln533Arg | p.Q533R | Q8TF40 | protein_coding | tolerated(0.08) | benign(0.039) | TCGA-A6-2672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
FNIP1 | SNV | Missense_Mutation | c.1300N>T | p.Arg434Cys | p.R434C | Q8TF40 | protein_coding | deleterious(0.04) | benign(0.222) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
FNIP1 | SNV | Missense_Mutation | novel | c.1759N>G | p.Thr587Ala | p.T587A | Q8TF40 | protein_coding | deleterious(0.05) | possibly_damaging(0.79) | TCGA-AA-A01D-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | capecitabine | PD |
FNIP1 | SNV | Missense_Mutation | c.872G>A | p.Arg291His | p.R291H | Q8TF40 | protein_coding | deleterious(0.01) | probably_damaging(0.999) | TCGA-AD-5900-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |